The US FDA in its communication mentioned it may withhold approval of any pending applications or supplements in which this facility is listed.
Indoco expects this change in compliance status to pave the way for approvals of ANDAs submitted from this site.
The interaction with key Government Officials and industry leaders led to a joint exploration of possible collaboration and investments in the Healthcare ecosystem between the two countries
Based on this inspection and the USFDA VAI classification, this facility is in compliance with regard to current good manufacturing practices (cGMP)
Fluor is providing architectural and engineering services and procuring equipment for the new 275,000 square-foot manufacturing facility that will house two manufacturing lines to double manufacturing capability
The investment will enable the company to enter European markets as well as enhance margins in current markets
Expanded capacity in Nansha, China will support mid-scale manufacturing to ensure a smooth transition between early-phase and large-scale commercial production
The company does not believe that the warning letter will have an impact on disruption of supplies or the existing revenues from operations of this facility
The new plant will include a wide range of dosage form capabilities for oral solids, liquids, topicals, films, and manufacturing technologies for granulation, film coating, spray drying, tableting
This win is on the back of a prestigious order from Reliance Life Sciences
Subscribe To Our Newsletter & Stay Updated
